Q4 2025 Management View Joseph Dowling, CEO, highlighted that "throughout 2025, we made meaningful progress against our top priorities, improving margins, reducing our cost structure and moving the ...
CV Sciences Inc. Annual cash flow by MarketWatch. View CVSI net cash flow, operating cash flow, operating expenses and cash dividends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results